I have seen well respected, well run, large multi-national companies with a list of collaborators that make SLA's look average pump hundreds of millions of dollars into drugs only to see them fail in phase III trials. So, in short, yes, I could see them putting all that work into something that in the end fails.
Answer me this question, what benefit does holding back the results actually give SLA? What can their competitors learn from the information?
Cheers,
Bill
SLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held